![](https://usercontent.one/wp/medimix.be/wp-content/uploads/sites/5/2023/12/michel-delforge-2.png)
ASH 2023 Highlight 4
Two investigations provide novel insights into optimizing the therapeutic approach for patients with newly diagnosed multiple myeloma (NDMM) presenting high-risk features. High-risk categorization is contingent upon specific FISH abnormalities, such